MedPath

VOCABRIA 600 mg SUSPENSION INYECTABLE DE LIBERACION PROLONGADA

VOCABRIA 600 mg SUSPENSION INYECTABLE DE LIBERACION PROLONGADA

Commercialized
Register Number

1201481003

Prescription Type

Diagnóstico Hospitalario

Authorization Date

Jan 20, 2021

Dosage Form

SUSPENSION INYECTABLE DE LIBERACION PROLONGADA

Route: VÍA INTRAMUSCULAR

Product Details

Detailed information about this CIMA AEMPS approved pharmaceutical product.

Basic Information

Key regulatory and product classification details

Regulatory Details

Register Number1201481003
EMA Approved
Yes

Drug Classification

Generic
No
Orphan
No
Biosimilar
No
Commercialized
Yes
CIMA AEMPS Classification

INGREDIENTS (1)

CABOTEGRAVIRActive
Quantity: 600 mg
Name: CABOTEGRAVIR

ATC CLASSIFICATION (3)

J05A
J05AJ
J05AJ04

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.